Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/17662
Citations | ||
Scopus | Web of ScienceĀ® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Callaghan, P. | - |
dc.contributor.author | Irvine, R. | - |
dc.contributor.author | Daws, L. | - |
dc.date.issued | 2005 | - |
dc.identifier.citation | Neurochemistry International: the journal for the publication of cellular and molecular aspects of neurochemistry, 2005; 47(5):350-361 | - |
dc.identifier.issn | 0197-0186 | - |
dc.identifier.issn | 1872-9754 | - |
dc.identifier.uri | http://hdl.handle.net/2440/17662 | - |
dc.description.abstract | Illicit use of p-methoxyamphetamine (PMA) is rapidly increasing. However, little is known about the acute effects of PMA on neurotransmission in vivo. High-speed chronoamperometry was used to monitor neurotransmitter release and clearance in anesthetized rats after local application of PMA or 3,4-methylenedioxymethamphetamine (MDMA). In striatum, PMA caused less neurotransmitter release than MDMA. PMA-evoked release could be partially blocked by pre-treatment with a serotonin (5-HT) reuptake inhibitor, suggesting that evoked 5-HT release contributed to the electrochemical signal and was mediated by the 5-HT transporter (SERT). MDMA-evoked release was not blocked by a SERT inhibitor, suggesting that primarily DA was released. To study the effect of these amphetamines on clearance of 5-HT mediated specifically by the SERT, clearance of exogenously applied 5-HT was measured in the CA3 region of the hippocampus. In contrast to the striatum where 5-HT is cleared by both the SERT and the dopamine transporter (DAT), 5-HT is cleared primarily by the SERT in the CA3 region. This is also a region where neither PMA nor MDMA evoked release of neurotransmitter. The maximal inhibition of 5-HT clearance was greater after PMA than MDMA. These data demonstrate in vivo (1) brain region variability in the ability of PMA and MDMA to evoke release of neurotransmitter; (2) that clearance of 5-HT in the striatum is mediated by both the SERT and the DAT; (3) distinct differences in the amount and nature of neurotransmitter released in the striatum after local application of PMA and MDMA and (4) that PMA is a more efficacious inhibitor of 5-HT clearance in the hippocampus than MDMA. These fundamental differences may account for the more severe adverse reactions seen clinically after PMA, compared to MDMA. | - |
dc.description.statementofresponsibility | Paul D. Callaghan, Rodney J. Irvine and Lynette C. Daws | - |
dc.description.uri | http://www.elsevier.com/wps/find/journaldescription.cws_home/643/description#description | - |
dc.language.iso | en | - |
dc.publisher | Pergamon-Elsevier Science Ltd | - |
dc.source.uri | http://dx.doi.org/10.1016/j.neuint.2005.04.026 | - |
dc.subject | Para-methoxyamphetamine | - |
dc.subject | 3,4-Methylenedioxymethamphetamine | - |
dc.subject | Serotonin transporter | - |
dc.subject | Dopamine transporter | - |
dc.subject | chronoamperometry | - |
dc.subject | Release | - |
dc.subject | uptake | - |
dc.title | Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1016/j.neuint.2005.04.026 | - |
pubs.publication-status | Published | - |
Appears in Collections: | Aurora harvest 2 Pharmacology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.